National Health Investors Secures Key Approvals for $560M Property Disposition
NHI is trading near its 52-week low of $68.8 (4.3% above the low).
Summary
National Health Investors announced that key regulatory and contractual conditions for its $560 million property disposition have been met, increasing the certainty of the deal's closing by July 1, 2026.
Key Events · M&A and Partnerships · NHI
-
Regulatory Approval Secured
The Hart-Scott-Rodino antitrust waiting period was terminated early on May 26, 2026, clearing a major regulatory hurdle for the disposition of 35 skilled nursing and independent living facilities.
-
Purchaser Waives Termination Rights
The purchaser waived its rights to terminate the Purchase and Sale Agreement during the review period, further solidifying the transaction.
-
Anticipated Closing Date Set
The company now anticipates the $560 million property disposition will close on or about July 1, 2026, subject to remaining customary conditions.
Analysis · NHI · Real Estate & Construction
This filing provides critical updates on the previously announced $560 million disposition of 35 healthcare facilities. The early termination of the HSR waiting period and the purchaser's waiver of termination rights remove significant regulatory and contractual contingencies, substantially de-risking the transaction. This increased certainty is a positive development for the company, especially as the stock trades near its 52-week low, and paves the way for the anticipated closing around July 1, 2026.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 35.7% of the 1024 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NHI was trading at $71.76 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $3.5B. The 52-week trading range was $68.80 to $91.38. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.